Type 2 Diabetes

Approximately 18 million Americans have type 2 diabetes and this number is growing as there are 1.8 million new cases per year reported in the US alone.

Upon diagnosis, patients present with 50% reduction in pancreatic beta cell mass. About half of theses patients become "insulin requiring" and then "insulin dependent". While some of the new agents for treatment of insulin resistance will help, the underlying problem is reduced islet mass.

CureDM is developing CDM1102 to treat type 2 diabetes.